|
Senseonics, a company developing an implantable continuous glucose monitoring (CGM) system announced that Eversense users who use the new app can
By: Laurie Block, RDN, CDE Looking back in review, 2019 was a year that many diabetes companies collaborated to form new partnerships to help make
One Drop, announced last week at the Diabetes Technology Meeting that it has developed a model to accurately predict blood glucose levels for
By: Laurie Block, RDN, CDE. Edited by: Suvarna Sheth. Diabetes management is changing rapidly. Every year, healthcare professionals and patients are
ForaCare Inc.’s new device, the FORA 6 Connect may revolutionalize diabetes management for individuals following the largely popular ketogenic
BOYDSense, Inc., a medical technology company, is developing a novel handheld device designed to accurately predict blood glucose values. The company
A new smart, portable carbohydrate monitoring system designed to enhance wellness by estimating carbohydrate metabolism based on measurements of
Senseonics Holdings, Inc., a company developing the first and only long-term, implantable continuous glucose monitoring (CGM) system for people with
Abbott and Omada Health announced today they are partnering to integrate Abbott’s FreeStyle Libre system, a continuous glucose monitoring (CGM)
Abbott and Tandem Diabetes Care announced today that they intend to team up to develop and commercialize integrated diabetes solutions. The
Get a little dLife delivered to your inbox every week.
Leave this field empty if you’re human: